NEW YORK (GenomeWeb) – Illumina has signed a 10-year lease at BioMed Realty's i3 campus in San Diego, BioMed said this week. The campus, which is under construction, will serve as an expansion of Illumina's headquarters. The company is expected to move in sometime in July 2017. The i3 campus will be comprised of three 100,000 square foot customizable buildings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.